Sanofi MenQuadfiRecent news mentioning Sanofi MenQuadfi2026-08-04 — Press Release: Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal diseaseAppears alongsidePress ReleaseBrowse the full archive →